MB-106
Mustang Bio
[]
#17icml: the data presented by dr. mazyar shadman show 95% orr and 80% cr rate across all patients; 100% orr and 91% cr with higher dose levels, including a patient previously treated with cd19-targeted car t-cell therapy. $mbio 
Mustang Bio, a Fortress Biotech company, is focused on the development of novel immunotherapies and gene therapies in areas of unmet need.